Skip To The Main Content

FDA expands opioids efforts to include guidance on managing acute pain

  • ADA News
The Food and Drug Administration announced Sept. 28 that immediate release opioids medications will now be subject to a "more stringent set of requirements" as part of the agency's efforts to address the nation's opioids crisis.
Silver Spring, Md. — The Food and Drug Administration announced Sept. 28 that immediate release opioids medications will now be subject to a "more stringent set of requirements" as part of the agency's efforts to address the nation's opioids crisis.

Immediate release opioids are used to treat acute pain and are often used in dental settings. They account for about 90 percent of all opioid pain medications prescribed, some 160 million prescriptions a year, FDA said. In July, the ADA urged FDA to expand its efforts to include the "nuances of managing acute, short-term pain following a one-time outpatient surgical procedure, particularly in dental settings." Previously FDA focused on extended release opioids used to manage chronic pain.

Read full FDA expands opioids efforts article

"State":"AK"